by Victor A McKusick and attended in 1968 by some young European participants, including the three of us. The support of the Istituto Gaslini (Genoa) and of the Federation of European Societies of Biochemistry (FEBS) made it possible to start the European equivalent of the Bar Harbor course 20 years later; this was quite labour-intensive as shown by its tight scientific schedule (Figure 3 ), consisting of morning lectures and afternoon practical workshops (but also characterized by long lunch breaks of about 2 h dedicated to the delicacies of Genoese cuisine…).
During subsequent years this model developed further into many more specialised courses (Cancer Genetics, Genetic Counselling, Molecular Cytogenetics, Eye Genetics, etc.) that became to be known as the European School of Genetic Medicine (ESGM). The 30th edition of the main ESGM course took place at the beginning of May 2017 in Bertinoro, Italy, with the new name 'Clinical Genomics and NGS'. It was attended by 89 students from all over the world (37 countries, Figure 4 ). Most of the ESGM courses have been supported consistently by ESHG fellowships. In what is more relevant for the history of ESHG, some of the highly motivated faculty of the 1988 course became the leaders of the reformed ESHG in later years, after the new statutes proposed by a committee consisting of Christos Bartsocas, Charles Buys, Marco Fraccaro, Peter Harper, Jan Mohr, Anne de Paepe and Eberhard Passarge) were approved and implemented in 1991 at the Leuven meeting where one of us (GR) took office as the first democratically elected ESHG President and went on to found the EJHG the following year. We have placed so much emphasis on the ESGM courses because we believe that the reform and expansion of the Society became possible in part through these courses, which enabled so many people to become acquainted with each other, breaking down national, regional and linguistic barriers.
Initially Jan Mohr, the founding secretary-general, contacted one of us (EP) in 1987 and suggested that he should take over as secretary-general in due time. Such a change appeared to be a good opportunity to make the ESHG more democratic and inclusive by electing a board (president, president-elect, secretary-general) and a programme committee. Supported by Peter Harper at the 1988 Cardiff meeting, the newly elected board took office in 1989 at the meeting in Groningen organised by Charles Buys (once again described by Peter Harper). All this happened at a time when Europe was going through great political changes-namely the fall of the Berlin Wall in November 1989, which led to the unification of East and West Germany in 1990, and the signing of major European treaties, such as Maastricht in 1993. It was a time of great enthusiasm and popular approval for the idea of building the European Union (EU) and implementing reforms, which for the first time in our history were being accomplished through peace and diplomacy.
In this climate of changes our small community of scientists was transformed into a democratic society of medical and clinical geneticists. We sometimes ask ourselves: was this achievement worth the time and effort invested in it? Among other indicators which can be used to answer this question, there is a simple observation based on the breakdown of students attending the main ESGM course in 1988 versus 2017 (Figures 1 and 4 respectively) . This comparison documents the success of ESHG in supporting programmes of advanced training in medical and clinical genetics that today are no longer limited to Europe but attract young geneticists from all over the world. This is a tangible result which shows that the reformed ESHG is having a tremendous impact on the practice and research in medical genetics far beyond Europe. The spirit that animated the European School of Genetic Medicine since its early days in Sestri Levante probably imprinted many young geneticists like Brunhilde Wirth (a student in the course of 1988; Figure 2 ) and Han Brunner (a young faculty member since the early '90s) who later became the driving force of the main ESGM course.
In conclusion, the reform of ESHG was useful, as evidenced by the universal acceptance and recognition of the Society's role in medicine and genetics. The success of the ESHG today is also shown by its excellent annual meetings under the guidance of its programme committee, and by its Journal that serves to unite geneticists from all over Europe and to let the rest of the world know what is happening in Europe. The three authors of this review were actively involved in the transformation of the ESHG from a somewhat loosely organized association to a well-organised scientific society in the late 1980s and early 1990s. AdlC and GR served as presidents during that period, EP as secretary-general, all elected by the membership assembly at annual meetings. During his Presidency GR founded the Journal, which he directed until 1995. His main interests are the scientific investigation of hereditary and congenital diseases and the application of this knowledge in genetic diagnosis and counseling. He is author or co-author of about 250 articles in international, peer-reviewed journals. His experience in academic teaching is reflected in his single author book Color Atlas of Genetics, its 5th edition in press, to be published by Thieme Medical Publishers Stuttgart-New York, in 2018.
EP was President of the German Society of Human Genetics 1990-1996, of which he became an honorary member in 2011. He is music coordinator at the University of Duisburg-Essen where he organizes the annual festive university concert. He was elected to be an honorary member of the university senate in 2016. He was awarded prizes from scientific institutions in Germany, Romania, Czech Republic, and India.
( 1990 -1991 , and President 1993 -1994 . His major honors include: Memberships in the Academy of Finland, the Royal Swedish Academy of Sciences and the US National Academy of Sciences. Dr de la Chapelle started as a cytogeneticist specializing in mechanisms of sex determination. He then turned to molecular genetics, pioneering the mapping and cloning of those Mendelian disorders that are enriched in the Finnish founder population, clarifying the molecular basis of over a dozen of these disorders. He is best known for his role in determining the molecular basis of hereditary cancer, notably the role of the mismatch repair genes in Lynch syndrome. He detected the phenomenon of microsatellite instability in hereditary cancer. He has pioneered the translation of these molecular events into clinical work and cancer prevention. Presently his laboratory is heavily committed to the study of the genetics of thyroid cancer.
